Send us Feedback

Altus Pharmaceuticals (ALTU)
Analysis
Data
Financials
 
 
 
 
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-JUN
2008		 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 newer
Cash & Equivalents 60.1M 41.2M 22.3M 5.96M 11.8M
Short Term Investments 32.7M 29.1M 26.3M 19.0M 0
Accounts Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Pre-paid Expenses 2.61M 5.26M 2.35M 1.56M 1.65M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 95.4M 75.5M 51.0M 26.6M 13.4M
Property, Plant & Equipment 4.92M 8.71M 9.60M 9.19M 7.94M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 4.16M 4.16M 3.70M 5.64M 5.17M
Total Long-Term Assets 9.09M 12.9M 13.3M 14.8M 13.1M
Total Assets 104M 88.4M 64.3M 41.4M 26.5M
Accounts Payable 1.48M 1.51M 1.68M 12.4M 8.01M
Accrued Expenses 1.51M 2.36M 0 0 0
Short Term Debt 4.65M 4.02M 3.95M 2.52M 2.87M
Other Current Liabilities 0 274K 0 0 0
Total Current Liabilities 15.3M 16.1M 16.5M 14.9M 10.9M
Long Term Debt 2.04M 1.74M 5.48M 3.89M 0
Capital Lease Obligations 4.35M 4.05M 5.64M 5.56M 2.97M
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 2.90M 6.50M 0 0 0
Total Long-term Liabilities 9.29M 12.3M 11.1M 9.45M 2.97M
Minority Interest 0 0 0 0 0
Total Liabilities 31.2M 35.1M 34.4M 31.1M 20.7M
Preferred Stock 0 0 0 0 0
Common Par 309K 311K 311K 311K 311K
Additional Paid-In Capital 362M 364M 365M 366M 367M
Retained Earnings -289M -311M -336M -356M -361M
Treasury Stock 0 0 0 0 0
Other Equity -46K -94K 197K 66K 0
Total Shareholder's Equity 73.3M 53.3M 29.9M 10.3M 5.83M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki